Grifols reported EUR0.29 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
Arca Biopharma USD -0.5 0.08 Mar/2025
aTyr Pharma USD -0.26 0.05 Sep/2025
Bio Path USD -0.4 0.33 Mar/2025
Brainstorm Cell Therapeutics USD -0.45 0.06 Mar/2025
Capricor Therapeutics USD -0.53 0.37 Mar/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Grifols EUR 0.29 0.03 Mar/2026
Immunic USD -0.24 0.03 Sep/2024
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024